Fennec Pharmaceuticals, Inc. FENC 深 滬
等待開盤 09-19 09:30:00 美东时间
5.22
-0.040
-0.76%
華盛通- 最 高5.315
- 今 開5.23
- 成交量 12.15万股
- 最 低 5.13
- 昨 收 5.26
- 總市值 1.41亿
- 52周最高 11.92
- 市盈率 靜 --
- 換手率 0.45%
- 52周最低 5.00
- 委 比 79.82%
- 總股本 2704.03万
- 歷史最高 14.986
- 量 比 1.53
- 振 幅 3.52%
- 歷史最低 3.255
- 每 手 1
- 風險率 1.82%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多快讯 | fennec pharmaceuticals股票：H.C. Wainwright将目标价从$15降至$13
Fennec Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $13 From $15
08-22 18:05
Fennec Pharmaceuticals Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-14 20:46
快讯 | fennec pharmaceuticals公司：Craig-Hallum将目标价从17美元降至15美元。
Fennec Pharmaceuticals, Inc. : Craig-Hallum Cuts Target Price to $15 From $17
08-14 19:31
快讯 | Fennec pharmaceuticals公司：Wedbush将目标价从16美元下调至14美元
Fennec Pharmaceuticals Inc : Wedbush Cuts Target Price to $14 From $16
08-14 12:04
Fennec Pharmaceuticals Welcomes New CEO, Posts Strong Q2
Fennec Pharmaceuticals (TSE:FRX) has released an update. Fennec Pharmaceuticals...
08-14 06:39
快讯 | fennec pharmaceuticals Q2营业费用美元指数1230.1万
Fennec Pharmaceuticals Q2 Operating Expenses USD 12.301 Million
08-13 18:05
快讯 | fennec pharmaceuticals报告了2024年第二季度的财务业绩并提供了业务更新
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provid...
08-13 18:05
Fennec Pharmaceuticals names Jeff Hackman as CEO
Fennec Pharmaceuticals (NASDAQ:FENC) said it has appointed Jeff Hackman as its CEO, effective on or about August 16. Hackman has more than three decades of commercial leadership experience. More on Fe...
08-05 18:53
快讯 | fennec pharmaceuticals任命Jeffrey S. Hackman为首席执行官和董事
Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer a...
08-05 18:26
新浪财经ESG：FENNEC PHARMACEUTI COM NPV 路孚特（Refinitiv）ESG评级调降至C-
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
07-22 07:00
